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• A palient .uflerlng Irom chronic active hepalltla with 
""CJonodular cirrhosis, positive lor hepatitis 8 surface anllien 
(HB"A;), was treated with an orthotopic nve, allograft. The HB. 
-"rlSlenemla, as measured with several predpltalion lests and by 
complement nutlon, became negative aHer transplantation and 
remained ao lor about 2% months. During the Inlerval, very low 
IterS of the anllgen were'delectable b, radlolmmunoa~uIK AI 
abOut Ihree months aner transplantalion, ahe had an anack 01 
.calle hepatHls, at which time H8"Ag became detectable b, all 
tests. She recoyered, but progressive Jlver disease de"eloped 
during the remaining 1% years 01 her life. She died ~f disseml-
naled noclrTdiOSls and candidiasis wllh delerloraling hepatic 
~nctionK The homograft at autops, showed no e"idence 01 
.ejection, but was the site of chronic active liver disease, 
although of a different palhologlc panern Ihan Ihal aHecting her 
naUve Jiver. The dlNerences In histology may reneel the Innuence 
cI chronic Immunosuppression on the features of chronic acllve 
hepatitis. 
(Aleh SUIg 114:75·78,1979) 
In K~u~st 1970, a patient with end-stage chronic aggres-sh'e hepatitis and cirrhosis, hepatitis B surface antigen 
IHB.Ag)' positive, was treated at the University· of 
Colorado Medical Center, Demer, by total replacement of 
the lh·er. Her dinical course is reported and discussed in 
this report, with particular reference to the inf~ction of the 
new liver by the hepatitis B \"irus. . 
REPORT OF A CASE 
1n 1964, a 22·year-01d v.·oman, a cbronic intra"enous drug user, 
-'U admitted to a Los Angeles hospital with acute "hepatitis. She 
,\n· .. ptcd for publication 1Iiay 16.1978-
Trom \M fepanm~ny of purg~ry (Dn Corman. Putnam. h ... t.suki, 
Schreter. anel SUrzl). Un;"rnity of Colorado Mrdical unLtr. aen~rr; the 
ffK-g~"m~nD of Medicine, Uni\enit)" of &!uth.,m Californi •• Rancho. Lm 
"",;,01 HospiLal, Do,,·n.,y (Dr gf~d~hrF; thr a~partm~ny of Patholor:r. St 
'!ary·. HospiLaI Medical School. London (prof PorlA!r); Ind a~partmtnt of 
hth01ocr, John "D·e~lry HospiLaI. Los ADlrlrs (Dr Peten). Dr Corman ia 
:.o.r with L 1Jnh'ersite d~ )Iontrral. HopiLaI Notre·Dame; Dr Polllam the 
~"ment of Surlery. Tocson (AnI) Veterans Administration Hospital; 
K~ Dr h .. atsuki the atparlm~nt of Surlery, io~Dola Uni-·tlS;t}" )hdical 
(" cr.' .. r. )fay ... ·ood. Ill. . 
'-li.lint nqutSts t.o a~pan m~nt of Surl.ry (BoJ: C305). t!ni\"trsity of 
C';'J"'.c1o !lltc1ical UnLtr. 4200 E Ninlll An, a~gfy"tDrK CO 80262 (Dr 
b •. ,]}. 
'Jch Surg-Vol ,,.., Jan 1979 
appeared to recover fully, but five yean later,jaundiee and ascites 
developed and she W.IS admitted to the Universit)' of Southeru 
California Liver Unit, John Wesley Hospital, Los Angeles. Tbe 
HB.Ag was positive by cOunt.ere1ec:trophoresis (CEP). 
.A liver biopsy spedmen '·as taken in 1969. At that time, the 
lobular architecture was comp1etel)' distorted by large discrete 
regenerative nodules.. There were scattered foci of hepa\.ocytolysis 
SWTOUndec1 br lymphocytes. )5any of the hepa\.ocyt.es .. ·ere 
banooned. The biopsy specimen was considered to represent a 
coarsely nodular cirrhotic liver in a relatively quiescent stage of 
chronic active hepatitiL 
(h;er the next year, there "'as progressi\le deterioration of liver 
function, necessitating several admissions to the hospital for the 
treatment of ascites, hepatic encepha10path)·, and gastrointestinaJ 
bleeding. In early August 1970, the patient ""as transferred to the 
Unh-ersity of Colorado Medical Center, Den\'er, for lh'er trans-
plantation. She had massive ascites, bnateral pleural effusions, 
and jaundIce. The laboratory findings (Fig 1) were typical of 
adunced cirrhosis, sho .. ;ng the foDov.·ing le,·els: serum total 
bilirubin. 6." mg/dl (direct. 4.6 mg/d!); SGOT. 240 JU; and alkaline 
phosphatase,330 IU. TIle prothrombin acth;ty was less than 2O'i. 
'The serum albumin level "'as 1.9 i/dl. and the f>erum globulin level 
was 4 g/d!. 
On Aug 9. 1970, she unde,..",'ent total hepatectomy, orthotopic 
lh·u transplantation.' and splenectomy. The procedure was made 
difficult by the portal hypertension and numerous "enous collaw-
alL During the operation, she required 18 units of blood. aD of 
.,,·hich "'ere negati"e for HB.Ag antibody by CEP. Aliquots of the 
transfusion blood were not '-ept for subsequent radioimmunoas.-
say. 
The t'"dst'd lher weighed 688 g (Fig 2). Jts lobular pattern " .. as 
entirely distorted by bulging ..... ell·defined. 0.5 lo 0.6 cm-regener-
ath'e nodules separaLed by loose connective tissue septa. }di~ 
s<:opicaJly, the discrete nodules were made up of markedly hychop-
it hepa\.ocl1.es v."ith "esicular nuclei. There .·ere only occ:asionaJ 
foci of hepat.oc:ytolysis, and most of the lymphocytic and plasma-
cytic infiltrates were confined to the loosel)' arranged fibrous 
septa. Kuptru uns "'ere only moderately prominent. 
Postoperath'ely, she '''IS treated .;th a triple "rug immunosup-
pressiv~ program consisting of aZathioprine or cyclophosphamide, 
prednisone. and horse antilymphocyte globulin'" (Fig i). Despite 
. her poor condition prior to transp1anlation. the early conules-
cence ""as une\"l:ntful and the patient was di~harged from the 
hospital 32 "ays afler the operation. Postoperath-ely, HB .... ' "'as 
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not detectable by CEP or agarose gel immunodiffusion (AG). 
Eighty days after transplantation, she was readmitted to the 
hospital with malaise, fever, arthralgia, and anorexia. There was a 
marked increase in the levels of the serum albumin, SGOT, and 
alkaline phosphatase (Fig 1); prothrombin activity was 50% of 
normal. Because of the reappearance of AG- and CEP-detectable 
HB.Ag, this illness was thought to be acute viral hepatitis. rather 
than a rejection episode. and her program of immunosuppression 
was therefore not altered. During the ensuing few weeks. there 
was further deterioration of hepatic function, and ascites was 
transiently present. Her condition then gradually improved, with 
return of the liver function test values to essentially normal levels 
(Fig 1). 
A needle biopsy of the liver was taken in September 1971. 
approximately 13 months after transplantation and ten months 
after the episode of acute hepatitis. Microscopically. this specimen 
showed a decidedly atypical pattern. with regularly arranged but 
more closely approximated portal structures from which irtsidious 
arachnoid collagen fibers extended varying distances into the 
lobules. The cord pattern was completely effaced by the hydropic 
parenchymal cells that formed irregularly distributed clusters of 
cells that bulged against adjacent areas of less swollen hepatC}o 
cytes. The central veins were difficult to find. but were normal 
when found. There was only a modest increase of cells in the portal 
areas. consisting mostly of duct epithelial cells. fibroblasts. endC}o 
thelial cells. and a few lymphocytes and plasma cells (Fig 3). 
The bloated hepatocytes had vesicular nuclei with prominent 
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nucleoli. Inflammatory infiltration into the lobule was meager, but 
there were occasional relatively inconspicuous clusters of Kupffet 
cells and a rare eosinophilic body, but no other frank necrosis (Fir 
4). Vascular structures in portal areas were not sclerotic. It wa. 
thought that the pattern probably represented an early stage of 
chronic active hepatitis. modified by immunosuppressive the", 
py. 
Soon after this. the patient was readmitted to the hospital with 
fever and headaches. A complete neurological evaluation wa. 
normal. A month later. Nocardia cuteroides was isolated frol1la 
skin nodule, and she was treated with sulfonamides.' She Wa. 
subsequently readmitted to the hospital on several more occasiolll 
with headaches and fever. By January 1972. seventeen montba 
after transplantation. her liver function had deteriorated (Fill) 
with recurrence of jaundice and ascites. In late Marcil 1972, foeaj 
neurologic signs developed. Craniotomy was performed. reveali'l 
multiple intracerebral NOt:ardia abscesses. Liver function conti .. 
ued to worsen. and she died of hepatic failure and neuroloric 
dysfunction on April 21. 1972, twenty months after transplanta. 
tion. At postmortem examination, multiple Nocardia asteroidt, 
and Candida albicans abscesses were found in the brain. heart, 
lungs. liver, and kidneys. 
The allografted liver at autopsy weighed 1.120 g. Since the liver 
was obtained from a male donor who weighed more than 70 kg, it. 
weight at the time of transplantation was estimated to have heeD 
1,800 g, based on.a liver weight/total body weight ratio of 2.5'l. 
The surface of the allograft had a fine. sandpaper appearance (Fir 
+ + + + + + + 
SERUM ~+-___ ~ ____ -L __ ~~=-____ am~~~~~~~~~~~ 
OR 
PROTEIN 41 
TOTAl- 4 
ALBUMIN ._--- 2 -" __ _ ----------------~ ------ ....... _- .. - - .", .... J" ... 
r GLOBULIN - - - zog +----r---------------------;KKKK-=-"-~-;KK;;-=-;K::-=::K::-=D-----------D-----D-=-
AZATHIOPRINE _ 100 
CYCLOPHOSPHAMIDE E::::l 0 
(mg) 100 
PREDNISONE (mg) 
f • PREDNI SOlONE (lg. i. y.) 
AlG 
100 300 400 
TRANSPLANTATION (8/9110) 
TIME IN DAYS 
Fig 1.-Clinical course of patient before and after liver replacement. AG indicates 
agarose gel immunodiffusion test for hepatitis B surface antigen; ALG. antilym-
phocyte globulin. 
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All 2.-Cut surface of shrunken nodular liver removed at time of 
pnsplantation on Aug 9. 1970 (x 2.4). 
Fig 3.-Uver biopsy specimen taken of allografted liver ten 
months after appearance of elevated transaminase activity and 
hepatitis in B surface antigen serum. Note widened portal tracts 
and bloated hepatocytes with very little lobular Inflammatory 
infiltrate (hematoxylin-eosin. x 120). 
Fig 4.-High-power photomicrographs of liver biopsy specimen shown in Fig 3. Hepatocytes are hydropic and nuclei are 
enlarged. with finely divided chromatin. Left. Eosinophilic body (arrows) is shown. Right. Focus of hepatocytolysis (arrows) filled 
with swollen Kupffer cells. macro phages. and a few lymphocytes (hematoxylin-eosin. x 600). 
FIg S.-Cut surface of allografted liver removed at autopsy. Note 
that liver. although toughened. is not CirrhotiC. and that portal 
Itructures are regularly distributed ( x 2.4). 
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Fig S.-Photomicrograph of allografted liver at autopsy. There are 
no fibrous septa incorporating portal areas (P). CentrHobular 
areas (C) are obliterated by fibrosis and there is diffuse interstitial 
fibrosis with collagen enveloping hepatocytes. (hematoxylin-
eosin. x 240). 
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Ji). The parenchyma was toughened. but the lobular architecture 
was intact (Fig 5) and the liver was not truly cirrhotic. Microscop-
ically, there were no regenerative nodules. The portal and central 
areas had a proper relationship to one another. However. there 
were fine collagen fibers that extended throughout the sinusoids. 
enveloping segments of hepatic cords that were arranged in 
restricted, acinar-like structures (Fig 6). The short hepatic cord 
structures were not arranged in a radial fashion. but were in 
disarray, The centrilobular areas had many finely foamy hepato-
cytes, with the vesicles ranging from about 1 to 3 It. Canaliculi 
were dilated with bile plugs. Kupffer cells were numerous and had 
unusually abundant cytoplasm. There was no exudate into the 
lobules, nor was there inflammatory hyperplasia in portal 
~onsK 
Serologic Studle. 
During the patient's hospital course. mUltiple serum s~imens 
were tested for the hepatitis B antigen in laboratories at the 
Universities of Southern California and Colorado by a variety of 
techniques, incIudingmicro-Ouchterlony agarose gel immunodif-
fusion, counterelectrophoresis, and complement fixation (CF) and 
radioimmunoassay (RIA).' 
Serum specimens tested in California at intervals during the 
year prior to transplantation were all positive (Fig 1) for HB,Ag 
by AG and CEP. These findings were confirmed in the same 
samples at the Colorado laboratories using all the methods but 
RIA. 
Serum samples were obtained for analysis in Colorado immedi-
ately before transplantation. after hepatectomy but before place-
ment of the homograft, and at 3D-minute intervals after revascu-
larization of the graft. The preoperative sample was positive in all 
test systems, while the specimen taken during the anhepatic phase 
was positive only with the more sensitive complement fixation 
test.· The five subsequent intraoperative serum samples were al1 
negative by the AG. CEP. and CF tests. 
The patient remained HB,Ag negative by the above techniques 
for 43 days after transplantation. At that time, although hepatic 
function tests were essentially normal, HB.Ag was again detect-
able, first by CF and later by CEP, Henceforth, until her death 18 
months later, all serum specimens tested were positive by all 
techniques. 
After the patient's death, serum samples that had been obtained 
during the early postoperative period (days 5, 9, 17, and 31) were 
retested ~y radioimmunoassay. Although these four samples had 
initially been found to be HB.Ag negative by AG, CEP, and CF. a11 
were positive by RIA (positively confirmed by blocking with 
anti-HB,AG antibody).' Hepatitis B surface antigen subtype 
determinations were done in the California laboratory. Both the 
pretransplant antigen and the antigen detected during the post-
transplant acute hepatitis were subtype ay. 
COMMENT 
The outcome aCter orthotopic hepatic transplantation in 
this patient was not readily predictable. It could be theo-
rized that the new and genetically different lh'er might be 
affected differently by the hepatitis virus than the nati\'e 
organ. Furthermore. the response of the new liver, iC 
infected. would be conditioned by an iatrogenically altered 
host immune response. 
Removal of the host liver resulted in an immediate. 
marked reduction in HB,Ag titer, suggesting that the liver 
was the major source of circulating H B.Ag. Apparently, 
the amount oC infectious material retained extrahepatical-
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ly, as reflected by the positive RIA test, was sufficient to 
infect the new organ. The only alternative, and an unlikely 
one since the HB.Ag screening tests oC the blood baths 
with CEP were negative, was that the inCection came from 
one of the blood transfusions. Whatever its origin, viral 
replication then occurred, presumably mainly in the freshly 
infected hepatic homograft, leading eventually to the 
release of large amounts of HB.Ag into the blood circula-
tion. The situation was thus somewhat comparable to post 
transfusion type B hepatitis. The development of clinical 
symptoms and biochemical abnormalities about 80 days 
after transplantation terminated the "incubation period," 
after which the less sensitive serologic tests readily 
detected HB.Ag in the serum. The bout of acute hepatitis 
at that time was not obviously different than would have 
been expected in a patient with a normal immune 
system. 
Although it was hoped that provision of new liver tissue 
of a different genetic constitution than the native organ or 
the use of an immunosuppressive program would protect 
against redevelopment of chronic active hepatitis, such was 
not the case in our patient. A chronic and progressive liver 
disorder developed, but one that was histologically dissim-
ilar to chronic active viral hepatitis in that collagen devel-
oped in fine intrasinusoidal strands not forming septa, 
hepatocyte regeneration was minimal, and inflammatory 
cell infiltration was meager. The histological features that 
developed in the liver homograft were also unlike the 
changes that can be induced by either rejection or immu-
nosuppression. It seems most likely that the posttransplan-
tation hepatic disorder in our patient was chronic active 
viral hepatitis modified by immunosuppression. 
In future cases, treatment should be considered at the 
time of operation to neutralize the residual virus with 
human anti-HB.Ag antibody. Successful therapy of this 
kind would make similar patients attractive candidates for 
liver replacement. One patient recently treated by us with 
hyperimmune serum has had complete clearing of HB.Ag 
for the entire 4th months of postoperative follow-up. It is 
not known to what extent this approach has been used at 
other centers. 
NonproprIetary Name and Trademark of Drug 
Azathioprine-1m uran. 
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